Reuters logo
BRIEF-Therapix Biosciences and Hannover Medical School enter into clinical trial agreement
2017年5月8日 / 下午1点02分 / 4 个月前

BRIEF-Therapix Biosciences and Hannover Medical School enter into clinical trial agreement

May 8 (Reuters) - Therapix Biosciences Ltd

* Therapix Biosciences and the Hannover Medical School enter into an investigator-initiated clinical trial agreement to assess the effect of txh-ts01 in patients with tourette syndrome

* Therapix Biosciences - entered into trial agreement with hannover medical school to conduct proof-of-concept phase ii clinical study with lead compound, thx-ts01

* Therapix Biosciences - trial agreement to conduct proof-of-concept phase ii clinical study with thx-ts01, for patients suffering from tourette syndrome Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below